Long

MRNA - Buy after a sell-off, Vaccines are here to stay

Updated

Vaccines are here to stay and many companies will have a good balance sheet in coming years. Moderna is a buy and I am DCAing from 186 down to every monthly dip.

MRNA will recover above 200 within 2022

Note

MRNA is simply bottoming, should be 200+ in a few months.

Note

Still waiting and expecting a decent rebound above 200.

Note

Good earnings, and a solid cash flow in MRNA...Ignoring the FUD.

Still MRNA is in business. Looking forward to 200+ finally.

Note

Pure sideways market - it is here to stay. I loaded more MRNA around 172.x. Can it deliver 225 this year? That should what we ask, instead SIG *Stay-in the Game*

cryptoshort

Also on:

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.